Hoth Therapeutics is a development stage biopharmaceutical company focused on targeted therapeutics for patients suffering from indications such as atopic dermatitis. The Company also develops the BioLexa Platform, a product candidate intended to prevent the symptom-triggering flare-ups before they occur.
|HQ||New York, NY, US||Map|
Net income (Q1, 2021)
EBIT (Q1, 2021)
Market capitalization (14-May-2021)
Closing stock price (14-May-2021)
|USD||Q3, 2017||Q3, 2018||Q1, 2019||Q2, 2019||Q3, 2019||Q1, 2020||Q2, 2020||Q1, 2021|
Depreciation and Amortization
Cash From Operating Activities
How many employees does Hoth Therapeutics have?
Hoth Therapeutics has 2 employees.
Who are Hoth Therapeutics competitors?
Competitors of Hoth Therapeutics include Alexion Pharmaceuticals, KiOmed Pharma and Veloxis Pharmaceuticals.
Where is Hoth Therapeutics headquarters?
Hoth Therapeutics headquarters is located at 1 Rockefeller Plaza, 10th Floor, New York.
Where are Hoth Therapeutics offices?
Hoth Therapeutics has an office in New York.
How many offices does Hoth Therapeutics have?
Hoth Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies